- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01187875
Resistant Starch and Satiety
March 28, 2012 updated by: University of Minnesota
Satiety Response of Resistant Starches
Dietary fiber consumption may contribute to weight regulation by improving satiety.
In an earlier study the investigators found that a muffin containing resistant starch was more effective than other fibers in altering satiety.
The objective of this study is to determine if 2 resistant starches consumed in muffins alter satiety and whether a mixture of resistant starches is more effective than either alone in enhancing satiety.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Saint Paul, Minnesota, United States, 55108
- University of Minnesota
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy men and women
- Age 18-64 years
- Non-smoking
- Not taking medication
- Non dieting (weight stable in prior 3 months)
- BMI 18-27
- English literacy
Exclusion Criteria:
- Do not regularly consume breakfast
- Food allergies to ingredients found in the study products
- BMI <18 or >27
- Diagnosed cardiovascular disease, renal disease, hepatic disease, or diabetes mellitus
- Cancer in previous 5 years
- Any gastrointestinal disease or condition
- Recent bacterial infection (< 3months)
- Recent or concurrent participation in an intervention research study
- History of drug or alcohol abuse in prior 6 months
- Use of lipid lowering, anti-hypertensive, or anti-inflammatory steroid medication
- Eating disorder
- Vegetarians
- People who eat more than approximately 15 grams of fiber per day
- Women who are pregnant or lactating
- Women with irregular menstrual cycles
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
Dextrin Control
|
Dextrin control administered in a muffin treatment.
|
|
Experimental: Hi-maize resistant starch 9g
|
9g Hi-maize resistant starch administered in a muffin treatment.
|
|
Experimental: Novalose 330 resistant starch 9g
|
9g Novalose 330 resistant starch administered in a muffin treatment.
|
|
Experimental: 4.5g Hi-maize and 4.5g Novalose 330
|
4.5g Hi-maize and 4.5g Novalose 330 in a muffin treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satiety response using visual analogue scales
Time Frame: 0 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
0 minutes postprandially
|
|
Satiety response using VAS
Time Frame: 15 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
15 minutes postprandially
|
|
Satiety response using VAS
Time Frame: 30 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
30 minutes postprandially
|
|
Satiety response using VAS
Time Frame: 45 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
45 minutes postprandially
|
|
Satiety response using VAS
Time Frame: 60 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
60 minutes postprandially
|
|
Satiety response using VAS
Time Frame: 90 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
90 minutes postprandially
|
|
Satiety response using VAS
Time Frame: 120 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
120 minutes postprandially
|
|
Satiety response using VAS
Time Frame: 180 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
180 minutes postprandially
|
|
Satiety response using VAS
Time Frame: 240 minutes postprandially
|
Satiety response was measured using subjective perceptions of hunger, fullness, satisfaction, and prospective food intake evaluated by previously validated visual analogue scales (VAS).
|
240 minutes postprandially
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ad libitum food intake
Time Frame: 240 minutes postprandially and over 24 hours
|
240 minutes postprandially and over 24 hours
|
|
|
Breath hydrogen response
Time Frame: 0, 240 minutes
|
0, 240 minutes
|
|
|
Gastrointestinal tolerance using visual analogue scales (VAS)
Time Frame: 24 hours
|
Subjective ratings of bloating, stool consistency, and flatulence on VAS.
A stool count was also recorded.
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joanne L Slavin, PhD, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
June 1, 2010
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
June 21, 2010
First Submitted That Met QC Criteria
August 23, 2010
First Posted (Estimate)
August 24, 2010
Study Record Updates
Last Update Posted (Estimate)
March 29, 2012
Last Update Submitted That Met QC Criteria
March 28, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 806M37445
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adults
-
Aix Marseille UniversitéNot yet recruitingHealthy Young Adults | Healthy Older AdultsFrance
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingHealthy Adult Participants | Non-smoking, Healthy Adults | Normal Weight AdultsSpain
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Samsung Medical CenterTerminatedHealthy Aging | Healthy AdultsKorea, Republic of
-
King Abdulaziz UniversityUniversity College Dublin; Royal College of Surgeons, IrelandRecruitingHealthy Adults | Healthy NutritionSaudi Arabia
-
Balgrist University HospitalNot yet recruiting
-
Essilor InternationalRecruiting
-
University of PennsylvaniaNational Institute on Aging (NIA)Not yet recruiting
-
MinicircleRecruiting
Clinical Trials on Placebo- Fiber free control
-
China Medical University HospitalUnknownImpaired Glucose ToleranceTaiwan
-
CargillCompletedSigns and Symptoms, Digestive
-
Meyer Children's Hospital IRCCSRecruitingJuvenile Idiopathic Arthritis (JIA)Italy
-
CargillCompletedSigns and Symptoms, Digestive
-
University of Illinois at Urbana-ChampaignActive, not recruiting
-
University of CalgaryGeneral MillsCompleted
-
University of FloridaSaskatchewan Pulse GrowersCompleted
-
University of FloridaSaskatchewan Pulse GrowersCompleted
-
Federico II UniversityCompletedHealthy | Overweight and ObesityItaly